Innovation and Product Development news (page 3)

• 

  28 July 2026

  Mitsui Chemicals joins CuspAI-led AI Materials Foundry as founding member

  Founding-member move ties chemical R&D to a 45+ partner network using CuspAI’s MIRA platform for end-to-end generative‑AI materials discovery.
• 

  27 July 2026

  argenx to acquire Forte Biosciences, adding anti‑CD122 candidate FB102

  FB102 shows Phase 1b proof in vitiligo and celiac; Phase 2 in celiac expected H2 2026. Acquisition executed as $77/share cash tender offer; close targeted Q3 2026.
• 

  27 July 2026

  Shengli Jiyang completes China's first continental rift lake basin shale‑oil demonstration area

  New three‑dimensional development model delivered two 100Mt fields, added 327Mt proven reserves, cut 6,000m well drilling to 17 days, raised single‑well output and reduced energy use.
• 

  26 July 2026

  BASF starts global registration for Replexor Active (fendioxypyracil)

  Novel PPO herbicide targets broadleaf weeds and key annual grasses; dossiers filed in Brazil and Australia with US and Argentina filings planned next year and market entry aimed ~2030.
• 

  24 July 2026

  Roche’s Susvimo recommended by CHMP for nAMD

  First continuous‑delivery ranibizumab implant for nAMD receives CHMP backing; designed to maintain vision with as few as two refills per year versus monthly injections.
• 

  24 July 2026

  Merck outlines LMIC access plans for alimatravir with 129‑country voluntary licenses

  Early, multi-faceted plan includes seven royalty‑free licenses covering 129 LMICs, regional manufacturing support in Africa and Latin America, and early manufacturing investment to speed availability.

• 

  24 July 2026

  Catalyxx to build €120M renewable chemicals plant at ZILS, Sines

  First commercial facility will convert bioethanol into butanol, hexanol and octanol, offering low‑carbon alternatives to petrochemical products.
• 

  23 July 2026

  Teijin and FUJIFILM Business Innovation achieve closed-loop recycling for multifunction-printer exterior parts

  An 80% recycled polycarbonate alloy resin is used to make remanufactured printer front covers with restored physical properties and white-color matching.
• 

  23 July 2026

  Aurora Renewable Carbon secures financing to restart Empyro plant

  Empyro will resume pyrolysis oil production from woody biomass residues this summer and add an upgrading unit to produce lignin- and sugar-based chemical feedstocks.
• 

  23 July 2026

  Genmab and AbbVie clarify EPCORE DLBCL-1 US primary endpoint not met

  The trial's sole U.S. primary endpoint—overall survival—did not reach statistical significance; additional results will be submitted for peer review.
• 

  23 July 2026

  BioBTX starts construction of PETRA circular aromatics plant

  First commercial plant directly converting mixed plastic waste into 10,000 t/yr BTX plus 8,000 t by-products; construction begins early 2027, start-up mid‑2028.
• 

  23 July 2026

  Johnson & Johnson: TECVAYLI + TALVEY reduce progression risk 89% and death risk 62% in earlier-line RRMM

  Phase 3 MonumenTAL-6 shows BCMA+GPRC5D bispecific combo and talquetamab+pomalidomide both significantly improved PFS versus investigator’s choice in patients with 1–4 prior lines.
• 

  23 July 2026

  Lilly's retatrutide shows large weight and A1C reductions in Phase 3 TRIUMPH‑2 and TRIUMPH‑3

  First‑in‑class triple agonist delivered large 80‑week weight losses and meaningful A1C and cardiometabolic improvements in difficult‑to‑treat obesity populations.
• 

  23 July 2026

  EIB study: Europe must boost mineral exploration tenfold to meet CRMA goals

  Study finds Europe needs a step-change in exploration spending and permitting reform to convert geological potential into domestic critical raw materials supply.
• 

  23 July 2026

  KMG‑Aero, KazFoodProducts and KBR advance Kazakhstan SAF project

  Two trilateral agreements set out a Process Design Package and a PURESAF ATJ licence to produce SAF from alcohol-based agricultural feedstocks.
• 

  22 July 2026

  GSK's Jideytro (zidesamtinib) approved in US for ROS1‑positive NSCLC

  FDA clears zidesamtinib for adults with advanced ROS1‑positive NSCLC after prior ROS1 inhibitor; ARROS‑1 showed 44% ORR and durable responses, including in brain metastases.
• 

  22 July 2026

  Takeda’s ORZEYFUL (oveporexton) approved in China as first OX2R agonist for narcolepsy type 1

  China approves first oral OX2R-selective orexin agonist for narcolepsy type 1 for patients 16 and older; Phase 3 trials reported improvements in sleepiness and cataplexy.
• 

  22 July 2026

  Timphaus farm adds EnviTec EnviThan biomethane upgrader in Lohne

  Family farm expands biogas plant to produce biomethane; construction began in January with grid injection planned for October.
• 

  22 July 2026

  Pirelli, Pyrum, Synthos and BASF launch tyre-to-tyre circular supply chain

  Converts end-of-life and scrap tyres into recovered carbon black, tyre pyrolysis oil and ISCC PLUS‑certified synthetic rubber for reuse in tyre production.
• 

  21 July 2026

  Teijin creates thermosetting CFRP with heat-activated self-heal and chemical recyclability

  Thermosetting long-carbon-fiber CFRP that is heat-repairable and chemically recyclable while retaining mechanical parity with conventional CFRPs.
• 

  21 July 2026

  CATL and Solarpro sign 2 GWh sodium‑ion storage deal for Eastern Europe

  2 GWh sodium‑ion storage agreement aims to deploy next‑gen systems and commission the first sodium‑ion energy storage project in Central and Eastern Europe.
• 

  21 July 2026

  SABIC and CEER sign MoU to explore materials collaboration for Saudi EVs

  MoU to assess advanced materials for EV applications, co-develop material and processing solutions, share sustainability know‑how and support a local supply chain for the Saudi EV sector.
• 

  21 July 2026

  Gilead & Merck: Once-weekly islatravir/lenacapavir (ISL/LEN) maintained viral suppression in Phase 3 ISLEND trials

  Phase 3 ISLEND-1/2 show once-weekly oral ISL/LEN noninferior to daily regimens at Week 48 with low discontinuations and similar safety profiles.
• 

  21 July 2026

  PTT Global Chemical wins BRIPC Best Practice Case in IP 2025 for muconic acid patent

  Patent for improved muconic acid commercialized; collaboration with Toray advanced bio-based adipic acid and pre-commercial Bio‑Nylon 6,6, supporting circular economy.
• 

  21 July 2026

  Evonik and Celtic Renewables partner to make ECOHANCE Soft BOL from bio-butanol

  Waste-derived bio-butanol is being used to produce a low-carbon cosmetic emollient; firms say switching to bio-based ingredients can cut product emissions by up to 60% and more uses are being explored.
• 

  20 July 2026

  Moeve Chemicals completes global verification for Low Carbon production

  All production plants verified to supply Low Carbon products, enabling global customers to access verified, traceable lower‑carbon LAB and phenol alternatives.
• 

  20 July 2026

  WuXi Biologics hits 1,000th molecule milestone with Earendil Labs trispecific antibody

  Trispecific ophthalmic antibody marks the platform's 1,000th molecule; collaboration advanced multiple multispecifics, fusion proteins and ADCs from DNA to IND with faster-than-average timelines.
• 

  20 July 2026

  Coolbrook and ABB advance RotoDynamic Heater to industrial delivery for Adani Cement

  Industrial-scale RotoDynamic Heater installation at Boyareddypalli cement plant; electrical equipment, drives and DCS supplied by partner; expected ~60,000 tCO2 reduction annually.
• 

  20 July 2026

  GSK Bexsero: EMA accepts submission to add single-dose booster for 10+ years

  Phase 3b data indicate a single Bexsero booster at age 10+ boosts immunity in those primed in infancy; full study results will be presented at IPNC in September.
• 

  17 July 2026

  Boehringer Ingelheim: EU approval for JASCAYD (nerandomilast) in IPF and PPF

  First-in-class oral PDE4B inhibitor approved for adults with IPF and PPF after Phase III trials showed slower lung function decline and a favourable tolerability profile.